Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers…
September 2026 write-ups: 1) $THRM RMT transaction (sort of a spin) 2) $CTVA $VYLR spin-off 3) Guide to M&A situations 4) $DECK beaten down (busted GARP) 5) $RAVE transitioning from turnaround to growth story https://t.co/fKWlrWNy4S
$CTVA rose nearly 3% after JPM upgraded the stock to overweight from neutral. It has a $19 price target on shares, implying 53% upside from Monday’s close. The bank said Corteva’s sharper focus on crop chemicals, along with improving agricultural commodity prices, should help
Consensus price target: $17.13 (+44.19% upside from $11.88)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| TITUS BRIAN See Remarks | Feb 20, 2026 | Sale | 4,000 | $306.13K |
| TITUS BRIAN See Remarks | Feb 20, 2026 | Sale | 4,311 | $330.07K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $17.4B | +2.92% | $1.09B |
| 2024 | $16.91B | -1.85% | $907M |
| 2023 | $17.23B | -1.31% | $735M |
Stock data for CTVA: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics